PAPER Yang Y, Cui M, Jin B, Wang X, Li Z, Yu P, Jia J, Fu H, Jia H, Liu B
SEARCH RESULTS
330029 RESULTS
PAPER Razavi SF, Khoobi M, Nadri H, Sakhteman A, Moradi A, Emami S, Foroumadi A, Shafiee A
Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
Eur J Med Chem. 2013 Jun;64:252-9. PubMed: 23644208PAPER Qin YY, Li MW, Zhang S, Zhang Y, Zhao LY, Lei H, Oishi K, Zhu WZ
In vivo quantitative whole-brain diffusion tensor imaging analysis of APP/PS1 transgenic mice using voxel-based and atlas-based methods.
Neuroradiology. 2013 Aug;55(8):1027-38. PubMed: 23644540PAPER Barone MC, Bohmann D
Assessing neurodegenerative phenotypes in Drosophila dopaminergic neurons by climbing assays and whole brain immunostaining.
J Vis Exp. 2013;(74):e50339. PubMed: 23644755PAPER Yang HT, Sheen YJ, Kao CD, Chang CA, Hu YC, Lin JL
Association between the characteristics of metabolic syndrome and Alzheimer's disease.
Metab Brain Dis. 2013 May 4; PubMed: 23644927PAPER Peters OM, Shelkovnikova T, Tarasova T, Springe S, Kukharsky MS, Smith GA, Brooks S, Kozin SA, Kotelevtsev Y, Bachurin SO, Ninkina N, Buchman VL
Chronic Administration of Dimebon does not Ameliorate Amyloid-β Pathology in 5xFAD Transgenic Mice.
J Alzheimers Dis. 2013 Jan 1;36(3):589-96. PubMed: 23645096PAPER Reckess GZ, Brandt J, Luis CA, Zandi P, Martin B, Breitner JC
Screening by Telephone in the Alzheimer's Disease Anti-inflammatory Prevention Trial.
J Alzheimers Dis. 2013 Jan 1;36(3):433-43. PubMed: 23645097PAPER Veszelka S, Tóth AE, Walter FR, Datki Z, Mózes E, Fülöp L, Bozsó Z, Hellinger E, Vastag M, Orsolits B, Környei Z, Penke B, Deli MA
Docosahexaenoic Acid Reduces Amyloid-β Induced Toxicity in Cells of the Neurovascular Unit.
J Alzheimers Dis. 2013 Jan 1;36(3):487-501. PubMed: 23645098PAPER Marchiani A, Mammi S, Siligardi G, Hussain R, Tessari I, Bubacco L, Delogu G, Fabbri D, Dettori MA, Sanna D, Dedola S, Serra PA, Ruzza P
Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties.
Amino Acids. 2013 Aug;45(2):327-38. PubMed: 23645386PAPER Lublin A, Link C
Alzheimer's Disease Drug Discovery: In-vivo screening using C. elegans as a model for β-amyloid peptide-induced toxicity.
Drug Discov Today Technol. 2013;10(1):e115-e119. PubMed: 23646059PAPER Macaskill MR, Anderson TJ
Whose name is it anyway? Varying patterns of possessive usage in eponymous neurodegenerative diseases.
PeerJ. 2013;1:e67. PubMed: 23646286PAPER Muñoz-Lobato F, Rodríguez-Palero MJ, Naranjo-Galindo FJ, Shephard F, Gaffney CJ, Szewczyk NJ, Hamamichi S, Caldwell KA, Caldwell GA, Link CD, Miranda-Vizuete A
Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases.
Antioxid Redox Signal. 2013 Jul 3; PubMed: 23641861PAPER Cummings JL, Dubois B, Molinuevo JL, Scheltens P
International Work Group criteria for the diagnosis of Alzheimer disease.
Med Clin North Am. 2013 May;97(3):363-8. PubMed: 23642575PAPER Rowe CC, Villemagne VL
Amyloid imaging with PET in early Alzheimer disease diagnosis.
Med Clin North Am. 2013 May;97(3):377-98. PubMed: 23642577PAPER Blennow K, Zetterberg H
The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.
Med Clin North Am. 2013 May;97(3):369-76. PubMed: 23642576Current Filters
No filters selected